The Defense Health Agency awarded a $999,540.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Governing Council of the University of Toronto, operating as the University of Toronto, to examine the link between hippocampal pathology and meningeal inflammation in progressive multiple sclerosis. The research project is scheduled to be completed by Aug 31, 2026. As a leading public research university, the University of Toronto has a history of collaborating on federal grant-funded projects across various scientific disciplines, including through subaward partnerships with other universities and companies.